Full name
PASSIMED SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
46.46.Z - Wholesale trade of pharmaceutical and medical products
2022 | 2023 | ||
---|---|---|---|
M PLN | M PLN | % | |
Profit (loss) on sale | 0,7 | 0,6 | -20,5 |
Gross profit (loss) | 0,7 | 0,6 | -20,8 |
EBITDA | 0,7 | 0,6 | -21,8 |
Short time liabilities | 0,9 | 1 | 16,8 |
Other operating costs | 0 | 0 | 0 |
Equity capital | 0,9 | 1,5 | 62 |
Operating profit (EBIT) | 0,7 | 0,6 | -20,8 |
Assets | 2,4 | 3,2 | 29,3 |
Net profit (loss) | 0,7 | 0,6 | -20,8 |
Cash | 0,9 | 1,3 | 50,5 |
Net income from sale | 8 | 7,1 | -11,4 |
Liabilities and provisions for liabilities | 1,5 | 1,7 | 9,6 |
Working assets | 2,4 | 3,2 | 29,3 |
Other income costs | 0 | 0 | -69,7 |
Depreciation | 0 | 0 | -100 |
% | % | p.p. | |
Profitability of capital | 78,3 | 38,3 | -40 |
Equity capital to total assets | 37,7 | 47,2 | 9,5 |
Gross profit margin | 9 | 8,1 | -0,9 |
EBITDA Margin | 9,2 | 8,1 | -1,1 |
Days | Days | Days | |
Short term commitment turnover cycle | 40 | 52 | 12 |
Current financial liquidity indicator | 2.8251616954803467 | 3.1269235610961914 | 0,3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane